cyclin-d1 and Hyperglycemia

cyclin-d1 has been researched along with Hyperglycemia* in 9 studies

Other Studies

9 other study(ies) available for cyclin-d1 and Hyperglycemia

ArticleYear
RING finger protein 10 is a potential drug target for diabetic vascular complications.
    Molecular medicine reports, 2019, Volume: 20, Issue:2

    Vascular remodeling induced by long‑term hyperglycaemia is the main pathological process in diabetic vascular complications. Thus, vascular remodeling may be a potential therapeutic target in diabetes mellitus (DM) with macrovascular disease. The present study aimed to investigate the effect of RING finger protein 10 (RNF10) on vascular remodeling under conditions of chronic hyperglycaemia stimulation. We found that overexpression of RNF10 clearly decreased intimal thickness and attenuated vascular remodeling in DM. TUNEL staining showed that apoptosis was clearly inhibited, an effect that may be mediated by decreases in Bcl‑2 protein expression. Quantitative analysis demonstrated that overexpression of RNF10 could suppress inflammation by reducing the levels of TNF‑α, and MCP‑1 mRNA and NF‑κB protein. Meanwhile, overexpression of RNF10 prevented vascular smooth muscle cell (VSMC) hyperproliferation through the downregulation of cyclin D1 and CDK4 proteins. Notably, short hairpin RNF10 (shRNF10) greatly aggravated the pathological responses of diabetic vascular remodeling. These outcomes revealed that the differential expression of RNF10 had a completely opposite effect on vascular damage under hyperglycaemia, further displaying the core function of RNF10 in regulating vascular remodeling induced by diabetes. Consequently, RNF10 could be a novel target for the treatment of diabetic vascular complications.

    Topics: Animals; Apoptosis; Carotid Arteries; Carrier Proteins; Chemokine CCL2; Cyclin D1; Cyclin-Dependent Kinase 4; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diet, High-Fat; Gene Expression Regulation; Humans; Hyperglycemia; Insulin Resistance; Male; Myocytes, Smooth Muscle; Nerve Tissue Proteins; NF-kappa B; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Signal Transduction; Tumor Necrosis Factor-alpha

2019
The cytotoxic role of intermittent high glucose on apoptosis and cell viability in pancreatic beta cells.
    Journal of diabetes research, 2014, Volume: 2014

    Glucose fluctuations are both strong predictor of diabetic complications and crucial factor for beta cell damages. Here we investigated the effect of intermittent high glucose (IHG) on both cell apoptosis and proliferation activity in INS-1 cells and the potential mechanisms.. Cells were treated with normal glucose (5.5 mmol/L), constant high glucose (CHG) (25 mmol/L), and IHG (rotation per 24 h in 11.1 or 25 mmol/L) for 7 days. Reactive oxygen species (ROS), xanthine oxidase (XOD) level, apoptosis, cell viability, cell cycle, and expression of cyclinD1, p21, p27, and Skp2 were determined.. We found that IHG induced more significant apoptosis than CHG and normal glucose; intracellular ROS and XOD levels were more markedly increased in cells exposed to IHG. Cells treated with IHG showed significant decreased cell viability and increased cell proportion in G0/G1 phase. Cell cycle related proteins such as cyclinD1 and Skp2 were decreased significantly, but expressions of p27 and p21 were increased markedly.. This study suggested that IHG plays a more toxic effect including both apoptosis-inducing and antiproliferative effects on INS-1 cells. Excessive activation of cellular stress and regulation of cyclins might be potential mechanism of impairment in INS-1 cells induced by IHG.

    Topics: Animals; Apoptosis; Cell Line; Cell Proliferation; Cell Survival; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Glucose; Hyperglycemia; Insulin-Secreting Cells; Oxidative Stress; Rats; Reactive Oxygen Species; Resting Phase, Cell Cycle; S-Phase Kinase-Associated Proteins; Time Factors; Up-Regulation; Xanthine Oxidase

2014
Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression.
    Nature, 2014, Jun-26, Volume: 510, Issue:7506

    Insulin constitutes a principal evolutionarily conserved hormonal axis for maintaining glucose homeostasis; dysregulation of this axis causes diabetes. PGC-1α (peroxisome-proliferator-activated receptor-γ coactivator-1α) links insulin signalling to the expression of glucose and lipid metabolic genes. The histone acetyltransferase GCN5 (general control non-repressed protein 5) acetylates PGC-1α and suppresses its transcriptional activity, whereas sirtuin 1 deacetylates and activates PGC-1α. Although insulin is a mitogenic signal in proliferative cells, whether components of the cell cycle machinery contribute to its metabolic action is poorly understood. Here we report that in mice insulin activates cyclin D1-cyclin-dependent kinase 4 (Cdk4), which, in turn, increases GCN5 acetyltransferase activity and suppresses hepatic glucose production independently of cell cycle progression. Through a cell-based high-throughput chemical screen, we identify a Cdk4 inhibitor that potently decreases PGC-1α acetylation. Insulin/GSK-3β (glycogen synthase kinase 3-beta) signalling induces cyclin D1 protein stability by sequestering cyclin D1 in the nucleus. In parallel, dietary amino acids increase hepatic cyclin D1 messenger RNA transcripts. Activated cyclin D1-Cdk4 kinase phosphorylates and activates GCN5, which then acetylates and inhibits PGC-1α activity on gluconeogenic genes. Loss of hepatic cyclin D1 results in increased gluconeogenesis and hyperglycaemia. In diabetic models, cyclin D1-Cdk4 is chronically elevated and refractory to fasting/feeding transitions; nevertheless further activation of this kinase normalizes glycaemia. Our findings show that insulin uses components of the cell cycle machinery in post-mitotic cells to control glucose homeostasis independently of cell division.

    Topics: Acetylation; Amino Acids; Animals; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cells, Cultured; Cyclin D1; Cyclin-Dependent Kinase 4; Diabetes Mellitus; Enzyme Activation; Fasting; Gene Deletion; Gluconeogenesis; Glucose; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hepatocytes; Histone Acetyltransferases; Homeostasis; Humans; Hyperglycemia; Hyperinsulinism; Insulin; Male; Mice; Phosphorylation; RNA, Messenger; Signal Transduction; Transcription Factors; Transcription, Genetic

2014
NAP reduces murine microvascular endothelial cells proliferation induced by hyperglycemia.
    Journal of molecular neuroscience : MN, 2014, Volume: 54, Issue:3

    Hyperglycemia has been identified as a risk factor responsible for micro- and macrovascular complications in diabetes. NAP (Davunetide) is a peptide whose neuroprotective actions are widely demonstrated, although its biological role on endothelial dysfunctions induced by hyperglycemia remains uninvestigated. In the present study we hypothesized that NAP could play a protective role on hyperglycemia-induced endothelial cell proliferation. To this end we investigated the effects of NAP on an in vitro model of murine microvascular endothelial cells grown in high glucose for 7 days. The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay and cyclin D1 protein expression analysis revealed that NAP treatment significantly reduces viability and proliferation of the cells. Hyperglycemia induced the activation of mitogen-activated protein kinase/extracellular signal-regulated protein kinase and/or phosphatidylinositol-3 kinase/Akt pathways in a time-dependent manner. NAP treatment reduced the phosphorylation levels of ERK and AKT in cells grown in high glucose. These evidences suggest that NAP might be effective in the regulation of endothelial dysfunction induced by hyperglycemia.

    Topics: Animals; Cell Line; Cell Proliferation; Cyclin D1; Endothelial Cells; Endothelium, Vascular; Glucose; Hyperglycemia; MAP Kinase Signaling System; Mice; Oligopeptides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt

2014
Insulin receptor-overexpressing β-cells ameliorate hyperglycemia in diabetic rats through Wnt signaling activation.
    PloS one, 2013, Volume: 8, Issue:7

    To investigate the therapeutic efficacy and mechanism of β-cells with insulin receptor (IR) overexpression on diabetes mellitus (DM), rat insulinoma (INS-1) cells were engineered to stably express human insulin receptor (INS-IR cells), and subsequently transplanted into streptozotocin- induced diabetic rats. Compared with INS-1 cells, INS-IR cells showed improved β-cell function, including the increase in glucose utilization, calcium mobilization, and insulin secretion, and exhibited a higher rate of cell proliferation, and maintained lower levels of blood glucose in diabetic rats. These results were attributed to the increase of β-catenin/PPARγ complex bindings to peroxisome proliferator response elements in rat glucokinase (GK) promoter and the prolongation of S-phase of cell cycle by cyclin D1. These events resulted from more rapid and higher phosphorylation levels of insulin-signaling intermediates, including insulin receptor substrate (IRS)-1/IRS-2/phosphotylinositol 3 kinase/v-akt murine thymoma viral oncogene homolog (AKT) 1, and the consequent enhancement of β-catenin nuclear translocation and Wnt responsive genes including GK and cyclin D1. Indeed, the higher functionality and proliferation shown in INS-IR cells were offset by β-catenin, cyclin D1, GK, AKT1, and IRS-2 gene depletion. In addition, the promotion of cell proliferation and insulin secretion by Wnt signaling activation was shown by 100 nM insulin treatment, and to a similar degree, was shown in INS-IR cells. In this regard, this study suggests that transferring INS-IR cells into diabetic animals is an effective and feasible DM treatment. Accordingly, the method might be a promising alternative strategy for treatment of DM given the adverse effects of insulin among patients, including the increased risk of modest weight gain and hypoglycemia. Additionally, this study demonstrates that the novel mechanism of cross-talk between insulin and Wnt signaling plays a primary role in the higher therapeutic efficacy of IR-overexpressing β-cells.

    Topics: Animals; beta Catenin; Blood Glucose; Cell Line; Cyclin D1; Diabetes Mellitus, Experimental; Disease Models, Animal; Gene Expression; Gene Expression Regulation; Glucokinase; Hyperglycemia; Insulin; Insulin-Secreting Cells; Male; Rats; Receptor, Insulin; Transcription, Genetic; Wnt Signaling Pathway

2013
Hyperglycemia slows embryonic growth and suppresses cell cycle via cyclin D1 and p21.
    Diabetes, 2013, Volume: 62, Issue:1

    In pregnant women, the diabetic condition results in a three- to fivefold increased risk for fetal cardiac malformations as a result of elevated glucose concentrations and the resultant osmotic stress in the developing embryo and fetus. Heart development before septation in the chick embryo was studied under two hyperglycemic conditions. Pulsed hyperglycemia induced by daily administration of glucose during 3 days of development caused daily spikes in plasma glucose concentration. In a second model, sustained hyperglycemia was induced with a single injection of glucose into the yolk on day 0. The sustained model raised the average plasma glucose concentration from 70 mg/dL to 180 mg/dL and led to decreased gene expression of glucose transporter GLUT1. Both models of hyperglycemia reduced embryo size, increased mortality, and delayed development. Within the heart outflow tract, reduced proliferation of myocardial and endocardial cells resulted from the sustained hyperglycemia and hyperosmolarity. The cell cycle inhibitor p21 was significantly increased, whereas cyclin D1, a cell cycle promoter, decreased in sustained hyperglycemia compared with controls. The evidence suggests that hyperglycemia-induced developmental delays are associated with slowed cell cycle progression, leading to reduced cellular proliferation. The suppression of critical developmental steps may underlie the cardiac defects observed during late gestation under hyperglycemic conditions.

    Topics: Animals; Blood Glucose; Cell Cycle; Cell Proliferation; Chick Embryo; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Embryonic Development; Female; Glucose Transporter Type 1; Heart Defects, Congenital; Humans; Hyperglycemia; Pregnancy; Pregnancy in Diabetics

2013
Diabetes in early pregnancy: getting to the heart of the matter.
    Diabetes, 2013, Volume: 62, Issue:1

    Topics: Animals; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Embryonic Development; Female; Humans; Hyperglycemia; Pregnancy

2013
PERK is required in the adult pancreas and is essential for maintenance of glucose homeostasis.
    Molecular and cellular biology, 2012, Volume: 32, Issue:24

    Germ line PERK mutations are associated with diabetes mellitus and growth retardation in both rodents and humans. In contrast, late embryonic excision of PERK permits islet development and was found to prevent onset of diabetes, suggesting that PERK may be dispensable in the adult pancreas. To definitively establish the functional role of PERK in adult pancreata, we generated mice harboring a conditional PERK allele in which excision is regulated by tamoxifen administration. Deletion of PERK in either young adult or mature adult mice resulted in hyperglycemia associated with loss of islet and β cell architecture. PERK excision triggered intracellular accumulation of proinsulin and Glut2, massive endoplasmic reticulum (ER) expansion, and compensatory activation of the remaining unfolded-protein response (UPR) signaling pathways specifically in pancreatic tissue. Although PERK excision increased β cell death, this was not a result of decreased proliferation as previously reported. In contrast, a significant and specific increase in β cell proliferation was observed, a result reflecting increased cyclin D1 accumulation. This work demonstrates that contrary to expectations, PERK is required for secretory homeostasis and β cell survival in adult mice.

    Topics: Animals; Base Sequence; Cell Proliferation; Cyclin D1; Diabetes Mellitus; eIF-2 Kinase; Endoplasmic Reticulum; Gene Knockout Techniques; Glucose; Homeostasis; Hyperglycemia; Insulin-Secreting Cells; Islets of Langerhans; Mice; Mice, Knockout; Pancreas; RNA, Messenger; Unfolded Protein Response

2012
Cyclin D2 is essential for the compensatory beta-cell hyperplastic response to insulin resistance in rodents.
    Diabetes, 2010, Volume: 59, Issue:4

    A major determinant of the progression from insulin resistance to the development of overt type 2 diabetes is a failure to mount an appropriate compensatory beta-cell hyperplastic response to maintain normoglycemia. We undertook the present study to directly explore the significance of the cell cycle protein cyclin D2 in the expansion of beta-cell mass in two different models of insulin resistance.. We created compound knockouts by crossing mice deficient in cyclin D2 (D2KO) with either the insulin receptor substrate 1 knockout (IRS1KO) mice or the insulin receptor liver-specific knockout mice (LIRKO), neither of which develops overt diabetes on its own because of robust compensatory beta-cell hyperplasia. We phenotyped the double knockouts and used RT-qPCR and immunohistochemistry to examine beta-cell mass.. Both compound knockouts, D2KO/LIRKO and D2KO/IRS1KO, exhibited insulin resistance and hyperinsulinemia and an absence of compensatory beta-cell hyperplasia. However, the diabetic D2KO/LIRKO group rapidly succumbed early compared with a relatively normal lifespan in the glucose-intolerant D2KO/IRS1KO mice.. This study provides direct genetic evidence that cyclin D2 is essential for the expansion of beta-cell mass in response to a spectrum of insulin resistance and points to the cell-cycle protein as a potential therapeutic target that can be harnessed for preventing and curing type 2 diabetes.

    Topics: Animals; Cyclin D1; Cyclin D2; Diabetes Mellitus, Experimental; Genotype; Homozygote; Hyperglycemia; Hyperplasia; Insulin Resistance; Insulin-Secreting Cells; Liver; Mice; Mice, Knockout; Receptor, Insulin; Reverse Transcriptase Polymerase Chain Reaction

2010